FDA Inspection 1007562 — Palmetto Health Richland-IRB
The FDA completed an inspection of Palmetto Health Richland-IRB on April 6, 2017 in Columbia, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbia, SC (United States)
Additional Details
IRB